{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.158G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "Mutant A53T α-Synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0006332"
  },
  "Experiment Method": [
    {
      "Assay Method": "Neuronal Cultures",
      "Material used": {
        "Material Source": "Primary cultures of rat cortical cells and mesencephalic neurons",
        "Material Name": "Primary cortical neurons and mesencephalic neurons",
        "Description": "Primary cultures of rat cortical cells were prepared from neonatal Wistar rats. Primary cultures of mesencephalic neurons were prepared from the mesencephali of mouse embryos at embryonic day 15."
      },
      "Readout type": "Qualitative and Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.158G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased autophagy and mitochondrial autophagy",
          "Result Description": "The overexpression of A53T α-synuclein led to an increase in the number of EGFP-LC3 positive autophagosomes and an increased number of mitochondria that colocalized with autophagosomes."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "At least 15 cell bodies or 18 axonal fragments were analyzed per group."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "The Mann-Whitney or Student’s t test and one-way ANOVA, followed by a Newman-Keuls posthoc test or Kruskal-Wallis test, followed by a Dunn’s test were used to compare the differences between the samples and the control group."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Neuronal cultures",
        "Material Name": "Primary cortical neurons and mesencephalic neurons",
        "Description": "For Western blot analysis, the cells were lysed and equivalent amounts of total protein were separated by SDS-PAGE and then transferred to membranes."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.158G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased LC3-I cleavage into LC3-II and increased turnover of p62/SQSTM1",
          "Result Description": "A53T α-synuclein overexpression enhanced LC3-I cleavage into LC3-II and increased the turnover of p62/SQSTM1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Primary antibodies were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No specific negative control mentioned, but the absence of primary antibody would serve as an implicit negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Densitometric analysis using a QuantityOne 710 System."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}